<
Application Data
(The endocytosis ratio vorsetuzumab by 786-O increased with the increase of antibody concentration, and the Internalization Rate (%) reached 55% at antibody concentration of 0.67 nM.)
TNFSF7/CD27L/CD70 recombinant antibody
Anti-TNFSF7/CD27L/CD70 Reference Antibody (vorsetuzumab)
Gene Names
CD70; CD27L; CD27LG; TNFSF7
Reactivity
Human
Applications
Functional Assay, Flow Cytometry, Functional Assay, ELISA
Synonyms
TNFSF7/CD27L/CD70, Recombinant Antibody; Anti-TNFSF7/CD27L/CD70 Reference Antibody (vorsetuzumab); TNFSF7/CD27L/CD70 recombinant antibody
Host
CHO Cell
Reactivity
Human
Clonality
Monoclonal
Isotype
IgG1
Specificity
TNFSF7/CD27L/CD70
Form/Format
Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.
Concentration
1mg/ml (varies by lot)
Applicable Applications for TNFSF7/CD27L/CD70 recombinant antibody
FA (Functional Assay), FCM/FACS (Flow Cytometry), ELISA
Endotoxin
< 0.001EU/ug, determined by LAL method.
Conjugation
Unconjugated
Dry Ice Shipment
Extra charge fee may add to your shipping cost as dry ice is required to ship this product.
Preparation and Storage
Store at -80 degree C for 2 years under sterile conditions; -20 degree C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
Application Data
(The endocytosis ratio vorsetuzumab by 786-O increased with the increase of antibody concentration, and the Internalization Rate (%) reached 55% at antibody concentration of 0.67 nM.)
Application Data
(The endocytosis ratio vorsetuzumab by 786-O increased with the increase of antibody concentration, and the Internalization Rate (%) reached 55% at antibody concentration of 0.67 nM.)
FCM/FACS (Flow Cytometry)
(HL-60 cells were stained with Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC150=0.06731 ug/mL)
FCM/FACS (Flow Cytometry)
(HL-60 cells were stained with Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC150=0.06731 ug/mL)
Application Data
(The purity of Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab)is more than 99.29% ,determined by SEC-HPLC.)
Application Data
(The purity of Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab)is more than 99.29% ,determined by SEC-HPLC.)
SDS-PAGE
(Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%)
SDS-PAGE
(Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%)
Product Categories/Family for TNFSF7/CD27L/CD70 recombinant antibody
NCBI and Uniprot Product Information
NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
Molecular Weight
21,118 Da
NCBI Official Full Name
CD70 antigen
NCBI Official Synonym Full Names
CD70 molecule
NCBI Official Symbol
CD70
NCBI Official Synonym Symbols
CD27L; CD27LG; TNFSF7
NCBI Protein Information
CD70 antigen; CD27-L; CD27 ligand; Ki-24 antigen; surface antigen CD70; tumor necrosis factor ligand superfamily member 7; tumor necrosis factor (ligand) superfamily, member 7
UniProt Protein Name
CD70 antigen
UniProt Gene Name
CD70
UniProt Synonym Gene Names
CD27L; CD27LG; TNFSF7; CD27-L
UniProt Entry Name
CD70_HUMAN
Similar Products
Product Notes
The TNFSF7/CD27L/CD70 cd70 (Catalog #AAA296804) is a Recombinant Antibody produced from CHO Cell and is intended for research purposes only. The product is available for immediate purchase. The Anti-TNFSF7/CD27L/CD70 Reference Antibody (vorsetuzumab) reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's TNFSF7/CD27L/CD70 can be used in a range of immunoassay formats including, but not limited to, FA (Functional Assay), FCM/FACS (Flow Cytometry), ELISA. Researchers should empirically determine the suitability of the TNFSF7/CD27L/CD70 cd70 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "TNFSF7/CD27L/CD70, Monoclonal Recombinant Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.